SCHEMBL4788381

SCHEMBL4788381

CS(=O)(=O)Oc1cccc(CC(NC2=NCCN2)c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.39
▸ HTR1B P28222 1/20 0.38
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ MAOA P21397 7/20 0.36
▸ MAOB P27338 7/20 0.36
▸ ITGB3 P05106 2/20 0.36
▸ ITGAV P06756 2/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ NISCH Q9Y2I1 7/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ WDR5 P61964 2/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4748418 0.95 FAAH (0.38) FAAHHTR1BSLC6A2SLC6A4MAOA
SCHEMBL4787543 0.89 ADRA2A (0.39) MAOAMAOBITGB3ITGAVITGA2B
Acetic Acid SCHEMBL4915061 0.85 ITGB3 (0.39) MAOAMAOBITGB3ITGAVITGA2B
SCHEMBL949042 0.80 KDM4E (0.52) MAOAMAOBNISCHKDM4EHTT
Iodide SCHEMBL951481 0.79 KDM4E (0.51) MAOAMAOBNISCHKDM4EHTT
SCHEMBL4748639 0.79 BCHE (0.46) MAOAMAOBITGB3ITGAVITGA2B
SCHEMBL4786568 0.79 HTR1B (0.49) HTR1BSLC6A2SLC6A4MAOAMAOB
SCHEMBL14042330 0.79 SLC6A2 (0.46) SLC6A2SLC6A4MAOAMAOBNISCH
SCHEMBL4788583 0.79 NISCH (0.43) MAOAMAOBNISCHKDM4EHTT
Iodide SCHEMBL949559 0.78 WDR5 (0.46) SLC6A2SLC6A4MAOAMAOBNISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 — — WO claimed
Send feedback